Form 4: Insider Trades at Macrogenics: Director Edward Hurwitz Acquires Shares

Director Edward Hurwitz of Macrogenics Inc. reported a transaction involving the acquisition of 3,750 shares of common stock.

Summary

• Director Edward Hurwitz acquired 3,750 shares of Macrogenics Inc. common stock on May 18, 2026.
• This acquisition follows the vesting of 3,750 Restricted Stock Units (RSUs) on the same date.
• Additionally, 3,750 RSUs were granted on May 19, 2026, scheduled to vest one year later or the day prior to the next annual meeting.
• A stock option to purchase 22,000 shares of common stock at an exercise price of $4.52 was also acquired on May 19, 2026, with monthly vesting.
• Following these transactions, Mr. Hurwitz beneficially owns 47,824 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions related to compensation and ownership rather than significant strategic shifts or performance indicators.

Positives

• Director Edward Hurwitz has increased his beneficial ownership of Macrogenics Inc. common stock.
• The acquisition of shares and stock options by a director can signal confidence in the company's future prospects.
• Vesting of RSUs on May 18, 2026, indicates that performance or time-based conditions were met.

Future Outlook

The filing indicates the future vesting of Restricted Stock Units and the exercise of stock options, suggesting potential future share acquisitions by management.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. Such filings are closely watched by investors as potential indicators of management's confidence in the company.

Stakeholder Impact

• Shareholders: Increased insider ownership may be viewed positively, indicating confidence in the company's long-term value.
• Management: These transactions are part of the compensation structure for directors and officers.

Next Steps

• Vesting of 3,750 RSUs on or before May 18, 2027 (or the day prior to the next annual meeting).
• Monthly vesting and exercisability of 22,000 stock options beginning one month from the grant date.

Key Dates

Keywords

Form 4, Insider Trading, Macrogenics Inc., MGNX, Edward Hurwitz, Director, Stock Options, Restricted Stock Units, Beneficial Ownership